Optimizing clinical outcomes for challenging molecules with lipid-based drug delivery
Pictured: OptiShell. All images courtesy of Catalent Pharma Solutions. © 2017 Catalent, Inc. All rights reserved
Implementing a bioavailability enhancing formulation approach can positively impact safety, efficacy, and patient adherence, leading to successful clinical outcomes. This article takes an in-depth look at how lipid-based drug delivery systems (LBDDS) can be used as a bioavailability enhancing technology, as well as the softgel dosage form for their delivery, in order to achieve successful clinical outcomes.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.